HITLAB, a leader in health innovation research, has partnered with Vistim Labs, an emerging pioneer in the evaluation of cognitive and neurodegenerative diseases, to validate their AI-powered brain-mapping algorithm for Alzheimer’s Disease progression and treatment response monitoring.
Laboratory compliance in the life sciences industry is crucial as it directly impacts patient safety, product quality, and data integrity. Pharmaceuticals, medical devices, diagnostics, and biotech firms are subject to strict regulations, including the FDA’s Good Manufacturing Practices (GMP), Good Clinical Practices (GCP), 21 CFR Part 11 (Electronic Records; Electronic Signatures), and the Clinical Laboratory Improvement Amendments (CLIA). These regulations create a framework that ensures operational excellence, covering aspects such as sample management, instrument compliance, personnel training, and adherence to standard operating procedures.
As we embark on a new year in digital health, HITLAB's leadership team would like to reflect on the significant achievements we've accomplished with our sponsors in 2024, as well as share an optimistic outlook for what lies ahead in 2025.
HITLAB is thrilled to announce the successful completion of the Fall 2024 semester of its Developing Emerging Leaders in Public Health Innovation (DELPHI) Internship Program.
The Proficient Lab (TPL) platform is an innovative solution designed to streamline laboratory workflows and foster seamless collaboration among life science sites and organizations.
Medcurio, a health tech company, is dedicated to enabling healthcare organizations to have complete real-time access and use of their Electronic Health Record (EHR) data to reduce the cost of care and improve access and quality.
HITLAB is proud to announce that Esther Dyson, renowned digital health expert and founder of Wellville, will be a featured speaker at the HITLAB Spring 2025 Summit.
The HITLAB Fall 2024 Digital Health Innovators Summit solidified its status as the largest digital health conference in New York City, bringing together thought leaders, innovators, and industry experts for three impactful days of exploration, networking, and cutting-edge insights.
HITLAB, the premier organization advancing digital health innovation, today announced the findings of its Level 3 Study on HelixVM, a transformative telemedicine platform.